Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term dapagliflozin and hemorheology in type 2 diabetes
jRCTs071180044Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of dapagliflozin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by AstraZeneca. Started Apr 2017; status: completed.
02
Drugs
dapagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCTs071180044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071180044.